10 Apr 2019 --- Suppliers of joint health solutions have questioned a recent assessment by French authorities which claims that supplements containing glucosamine or chondroitin sulfate may cause adverse reactions among certain groups. The French Agency for Food, Environmental and Occupational Health & Safety’s (ANSES) nutrivigilance scheme is advising that certain populations, such as diabetics, avoid consuming food supplements containing the flagged ingredients. However, key players in the joint health market point to the “limited evidence available” in relation to the claims, and are keen to reassure patients that there are no safety concerns over these ingredients. They do suggest that clear-on pack labeling, as well as EU-wide regulation of certain joint health ingredients, could be useful for this growing market.